"The entire discussion about whether aging is a disease is actually little more than a distraction from the real, more technical issues standing in the way of getting a medicine that enhances healthspan from being approved for that use."
— @CambrianBiohttps://longevity.technology/cambrian-biopharma-juliette-han-qa/ …
-
-
yes, we are their largest investor from the Series A:https://flic.kr/p/2kAxc2o
-
terrific!
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
